SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Drummond MF, Stoddart GL, Torrance GW. Critical assessment of economic evaluation. In: DrummondMF, StoddartGL, TorranceGW, editors. Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford University Press; 1990. p. 1835.
  • 2
    Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read clinical journals: VII. To understand an economic evaluation (part A). Can Med Assoc J 1984; 130: 142834.
  • 3
    Ruof J, Huelsemann JL, Stucki L. Evaluation of costs in rheumatic diseases: a literature review. Curr Opin Rheumatol 1999; 11: 1049.
  • 4
    Rothfuss J, Mau W, Zeidler H, Brenner MH. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: a literature review. Semin Arthritis Rheum 1997; 26: 7719.
  • 5
    Ruof J, Merkesdal S, Huelsemann JL, Schoeffski O, Maetzel A, Mau W, et al. Cost assessment instruments in rheumatology: evaluation of applied instrument characteristics. J Rheumatol 2001; 28: 6625.
  • 6
    Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993; 36: 154859.
  • 7
    Guzman J, Pelosi P, Bombardier C. Capturing health care utilization after occupational low-back pain: development of an interviewer-administered questionnaire. J Clin Epidemiol 1999; 52: 41927.
  • 8
    Goossens MEJB, Rutten-van Mölken MPMH, Vlaeyen JWS, van der Linden SMJP. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53: 68895.
  • 9
    Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of health care utilization compared to provider records. J Clin Epidemiol 2001; 54: 13641.
  • 10
    Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997; 40: 156070.
  • 11
    Merkesdal S, Ruof J, Huelsemann JL, Schoeffski O, Maetzel A, Mau W, et al. Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis. J Rheumatol 2001; 28: 65761.
  • 12
    Mittendorf T, Merkesdal S, Huelsemann JL, von der Schulenburg JM, Zeidler H, Ruof J. Implementing standardized cost categories within economic evaluations in musculoskeletal diseases. Eur J Health Econ 2003; 4: 439.
  • 13
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 14
    AOK. Die Gesundheitskasse für Niedersachsen. Geschäftsbericht 2000. Hannover: Grütter; 2001.
  • 15
    Mundenbruch R. BMAE, E-GO, EBM: Gegenueberstellung mit Abrechnungshinweisen. Dachau: Zeuner, Druck-und Verlags GmbH; 2000.
  • 16
    Ruof J, Huelsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, et al. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on objective data sources. Ann Rheum Dis 2003; 62: 5449.
  • 17
    Kramer MS, Feinstein AR. Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 1981; 29: 11123.
  • 18
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1989; I: 30710.
  • 19
    Brosius G, Brosius F. SPSS base system and professional statistics. Koesel, Kempten: International Thomson Publishing; 1995.
  • 20
    Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ. Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 1996; 49: 98995.
  • 21
    Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997; 24: 71925.
  • 22
    Girard F, Guillemin F, Novella JL, Vlackenaere I, Krzanowska K, Virty F, et al. Health-care use by rheumatoid arthritis patients compared with non-arthritis subjects. Rheumatology (Oxford) 2002; 41: 16775.